BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11583876)

  • 1. Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventions.
    Meisel C; Afshar-Kharghan V; Cascorbi I; Laule M; Stangl V; Felix SB; Baumann G; López JA; Roots I; Stangl K
    J Am Coll Cardiol; 2001 Oct; 38(4):1023-7. PubMed ID: 11583876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study.
    Laule M; Cascorbi I; Stangl V; Bielecke C; Wernecke KD; Mrozikiewicz PM; Felix SB; Roots I; Baumann G; Stangl K
    Lancet; 1999 Feb; 353(9154):708-12. PubMed ID: 10073513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet membrane glycoprotein Ibalpha gene -5T/C Kozak sequence polymorphism as an independent risk factor for the occurrence of coronary thrombosis.
    Douglas H; Michaelides K; Gorog DA; Durante-Mangoni E; Ahmed N; Davies GJ; Tuddenham EG
    Heart; 2002 Jan; 87(1):70-4. PubMed ID: 11751671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet glycoprotein Ibalpha gene polymorphism and massive or submassive pulmonary embolism.
    Soylu A; Tokaç M; Cora T; Düzenli MA; Acar H
    J Thromb Thrombolysis; 2009 Apr; 27(3):259-66. PubMed ID: 18283530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene.
    Mrozikiewicz PM; Cascorbi I; Ziemer S; Laule M; Meisel C; Stangl V; Rutsch W; Wernecke K; Baumann G; Roots I; Stangl K
    J Am Coll Cardiol; 2000 Nov; 36(5):1520-5. PubMed ID: 11079652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex.
    Afshar-Kharghan V; Li CQ; Khoshnevis-Asl M; López JA
    Blood; 1999 Jul; 94(1):186-91. PubMed ID: 10381512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A1166C polymorphism of the angiotensin II type 1 receptor gene and risk of adverse events after coronary catheter interventions.
    Stangl K; Cascorbi I; Stangl V; Laule M; Mrozikiewicz PM; Schwarz M; Felix SB; Theres H; Baumann G; Roots I
    Am Heart J; 2000 Jul; 140(1):170-5. PubMed ID: 10874281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet glycoprotein Ibalpha HPA-2 Met/VNTR B haplotype as a genetic predictor of myocardial infarction and sudden cardiac death.
    Mikkelsson J; Perola M; Penttilä A; Karhunen PJ
    Circulation; 2001 Aug; 104(8):876-80. PubMed ID: 11514372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients.
    Kenny D; Muckian C; Fitzgerald DJ; Cannon CP; Shields DC
    J Thromb Thrombolysis; 2002 Feb; 13(1):13-9. PubMed ID: 11994555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kozak sequence polymorphism of platelet glycoprotein Ibalpha and risk of nonfatal myocardial infarction and nonfatal stroke in young women.
    Frank MB; Reiner AP; Schwartz SM; Kumar PN; Pearce RM; Arbogast PG; Longstreth WT; Rosendaal FR; Psaty BM; Siscovick DS
    Blood; 2001 Feb; 97(4):875-9. PubMed ID: 11159511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke.
    Baker RI; Eikelboom J; Lofthouse E; Staples N; Afshar-Kharghan V; López JA; Shen Y; Berndt MC; Hankey G
    Blood; 2001 Jul; 98(1):36-40. PubMed ID: 11418460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.
    Kastrati A; Koch W; Gawaz M; Mehilli J; Böttiger C; Schömig K; von Beckerath N; Schömig A
    J Am Coll Cardiol; 2000 Jul; 36(1):84-9. PubMed ID: 10898417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Platelet Membrane Glycoprotein HPA-2a/b, GP VI T13254C, and GP Ib
    Ni W; He J; Wang H; Liu T
    Biomed Res Int; 2017; 2017():1538750. PubMed ID: 28607925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
    Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does platelet glycoprotein IIb/IIIa receptor antibody improve in-hospital outcome of coronary stenting in high-risk thrombus containing lesions?
    Piamsomboon C; Wong PM; Mathur A; Singh D; Liu MW; Baxley WA; Iyer SS; Dean LS; Roubin GS
    Catheter Cardiovasc Interv; 1999 Apr; 46(4):415-20. PubMed ID: 10216005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms.
    Macchi L; Christiaens L; Brabant S; Sorel N; Ragot S; Allal J; Mauco G; Brizard A
    J Am Coll Cardiol; 2003 Sep; 42(6):1115-9. PubMed ID: 13678940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet functional implications of glycoprotein Ibalpha polymorphisms in African Americans.
    Williams MS; Ng'alla LS; Vaidya D
    Am J Hematol; 2007 Jan; 82(1):15-22. PubMed ID: 16986133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The variable number of tandem repeat polymorphism of platelet glycoprotein Ibalpha and risk of coronary heart disease.
    Afshar-Kharghan V; Matijevic-Aleksic N; Ahn C; Boerwinkle E; Wu KK; López JA
    Blood; 2004 Feb; 103(3):963-5. PubMed ID: 14592833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet polymorphisms and ischemic heart disease: moving beyond traditional risk factors.
    Kandzari DE; Goldschmidt-Clermont PJ
    J Am Coll Cardiol; 2001 Oct; 38(4):1028-32. PubMed ID: 11583877
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet glycoprotein Ibalpha polymorphisms modulate the risk for myocardial infarction.
    Ozelo MC; Origa AF; Aranha FJ; Mansur AP; Annichino-Bizzacchi JM; Costa FF; Pollak ES; Arruda VR
    Thromb Haemost; 2004 Aug; 92(2):384-6. PubMed ID: 15269835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.